The startup was founded by Steve Kirsch, a wealthy serial entrepreneur, who has founded six companies, including Mouse Systems, Frame Technology, Infoseek, Propel, Abaca, and OneID.
Given the limitation of using mouse systems to develop human therapeutics, the use of these approaches can provide more physiologically relevant insight into disease pathology and help to identify more efficacious drug targets.
In addition, recent advances on genetically engineered techniques such as cell-specific and inducible knockout as well as knockin mouse systems have brought novel concepts on IBD pathogenesis to the fore.
Our results demonstrated that the DNA immunization of rats through intramuscular injection was a simple and easily available method of producing polyclonal antibodies that can be used to detect and analyze mouse TIGIT expression in mouse systems.
Steven Kirsch, whose past startup successes include Mouse Systems, FrameMaker and Infoseek, says that "people are very hard to change" and admits that he has made many of the same mistakes at all of the companies he has led over the years.
Beyond Infoseek, which Kirsch sold to for a reported $1.7 billion, he is one of the co-inventors of (and holds one of the original patents to) an early version of the optical mouse, which behind Kirsch's vehicle Mouse Systems, helped bring the optical mouse to IBM PCs.
Some of these included Broderbund's Dazzle Draw for the Apple II, Mouse Systems' PC Paint for the PC, and IBM's Color Paint for the IBM PCjr.
Clone AIIB2 was used to inhibit β1 subunit function in both human and mouse systems [70].
This method has the effect of combining information from the expert nomination process and the mouse systems genetics data.
